JP2001509373A5 - - Google Patents

Download PDF

Info

Publication number
JP2001509373A5
JP2001509373A5 JP2000502082A JP2000502082A JP2001509373A5 JP 2001509373 A5 JP2001509373 A5 JP 2001509373A5 JP 2000502082 A JP2000502082 A JP 2000502082A JP 2000502082 A JP2000502082 A JP 2000502082A JP 2001509373 A5 JP2001509373 A5 JP 2001509373A5
Authority
JP
Japan
Prior art keywords
hvem
ltβr
pharmaceutical composition
binding substance
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000502082A
Other languages
English (en)
Japanese (ja)
Other versions
JP4712966B2 (ja
JP2001509373A (ja
Filing date
Publication date
Priority claimed from US08/898,234 external-priority patent/US6140467A/en
Application filed filed Critical
Publication of JP2001509373A publication Critical patent/JP2001509373A/ja
Publication of JP2001509373A5 publication Critical patent/JP2001509373A5/ja
Application granted granted Critical
Publication of JP4712966B2 publication Critical patent/JP4712966B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000502082A 1997-07-07 1998-07-07 単純ヘルペスウイルス侵入メディエーターのためのリガンドおよびその使用方法 Expired - Fee Related JP4712966B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5196497P 1997-07-07 1997-07-07
US08/898,234 1997-07-30
US60/051,964 1997-07-30
US08/898,234 US6140467A (en) 1997-07-07 1997-07-30 Ligand for herpes simplex virus entry mediator and methods of use
PCT/US1998/013897 WO1999002563A1 (en) 1997-07-07 1998-07-07 Ligand for herpes simplex virus entry mediator and methods of use

Publications (3)

Publication Number Publication Date
JP2001509373A JP2001509373A (ja) 2001-07-24
JP2001509373A5 true JP2001509373A5 (cg-RX-API-DMAC7.html) 2006-01-05
JP4712966B2 JP4712966B2 (ja) 2011-06-29

Family

ID=26730006

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000502082A Expired - Fee Related JP4712966B2 (ja) 1997-07-07 1998-07-07 単純ヘルペスウイルス侵入メディエーターのためのリガンドおよびその使用方法

Country Status (11)

Country Link
US (1) US6140467A (cg-RX-API-DMAC7.html)
EP (1) EP1003782B1 (cg-RX-API-DMAC7.html)
JP (1) JP4712966B2 (cg-RX-API-DMAC7.html)
KR (1) KR100620334B1 (cg-RX-API-DMAC7.html)
CN (2) CN1891714B (cg-RX-API-DMAC7.html)
AT (1) ATE495240T1 (cg-RX-API-DMAC7.html)
AU (1) AU741419B2 (cg-RX-API-DMAC7.html)
CA (1) CA2296737C (cg-RX-API-DMAC7.html)
DE (1) DE69842096D1 (cg-RX-API-DMAC7.html)
TW (1) TWI222453B (cg-RX-API-DMAC7.html)
WO (1) WO1999002563A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635743B1 (en) 1996-03-22 2003-10-21 Human Genome Sciences, Inc. Apoptosis inducing molecule II and methods of use
US6479254B2 (en) 1996-03-22 2002-11-12 Human Genome Sciences, Inc. Apoptosis inducing molecule II
US6495520B2 (en) 1996-03-22 2002-12-17 Human Genome Sciences, Inc. Apoptosis Inducing Molecule II and methods of use
US7964190B2 (en) 1996-03-22 2011-06-21 Human Genome Sciences, Inc. Methods and compositions for decreasing T-cell activity
US6998108B1 (en) 1997-07-07 2006-02-14 La Jolla Institute For Allergy And Immunology Antibodies to p30 polypeptides and methods making and using same
US7118742B2 (en) * 1997-07-07 2006-10-10 La Jolla Institute For Allergy And Immunology Ligand for herpes simplex virus entry mediator and methods of use
WO2000010591A1 (en) * 1998-08-18 2000-03-02 The Trustees Of The University Of Pennsylvania Peptides for inhibition of herpes simplex virus entry
WO2001079496A2 (en) * 2000-03-13 2001-10-25 La Jolla Institute For Allergy And Immunology Ligand for herpes simplex virus entry mediator and methods of use
AU2007201279B2 (en) * 2000-03-13 2011-05-26 La Jolla Institute For Allergy And Immunology Ligand for herpes simplex virus entry mediator and methods of use
ATE365214T1 (de) 2000-04-12 2007-07-15 Jolla Inst Allergy Immunolog Ligand des zelleintritt-vermittelnden proteins von herpes simplex und methoden zu dessen verwendungen
WO2002032463A1 (en) * 2000-10-18 2002-04-25 Smithkline Beecham Corporation Methods of treating cancers by stimulating dendritic cells or lymphomas with certain tnf molecules
US7514407B2 (en) * 2002-03-04 2009-04-07 Nymox Corporation Spheron component peptides and pharmaceutical compositions
US7811983B2 (en) * 2003-06-11 2010-10-12 The University Of Chicago Increased T-cell tumor infiltration and eradication of metastases by mutant light
ATE382372T1 (de) * 2003-06-11 2008-01-15 Univ Chicago Erhöhte t-zell tumor-eindringung durch light- mutanten
EP2484696B1 (en) 2006-08-28 2017-08-16 Kyowa Hakko Kirin Co., Ltd. Antagonistic hLIGHT-specific human monoclonal antibodies
WO2008098183A2 (en) * 2007-02-08 2008-08-14 The University Of Chicago Combination therapy for treating cancer
JP2012507299A (ja) * 2008-10-31 2012-03-29 バイオジェン・アイデック・エムエイ・インコーポレイテッド Light標的分子およびその使用
GB201701194D0 (en) 2017-01-24 2017-03-08 Capella Bioscience Ltd Antigen binding molecules that bind light
CN107213456B (zh) * 2017-05-25 2020-08-21 苏州华测生物技术有限公司 淋巴毒素衍生物的新用途
US11312781B2 (en) 2018-01-24 2022-04-26 Capella Bioscience Ltd. Antigen binding molecules that bind LIGHT
WO2019238966A1 (en) * 2018-06-15 2019-12-19 Universität Bern LIGANDS TO LIGHT OR ITS RECEPTOR LTßR FOR USE IN HAEMATOLOGIC MALIGNANCIES
CA3173873A1 (en) 2020-04-01 2021-10-07 Avalo Therapeutics, Inc. Methods and treatment involving excess free light
CN112511569B (zh) * 2021-02-07 2021-05-11 杭州筋斗腾云科技有限公司 网络资源访问请求的处理方法、系统及计算机设备

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ298711B6 (cs) * 1995-01-26 2008-01-02 Biogen Idec Ma Inc. Farmaceutické prostredky aktivující LT-beta receptor pro lécení nebo omezení pokracování, závažnosti nebo úcinku neoplazie, zpusob selekce LT-beta receptor aktivujícího cinidla a protilátky proti LT-beta receptoru
AU2363695A (en) * 1995-04-27 1996-11-18 Human Genome Sciences, Inc. Human tumor necrosis factor receptors
US5654174A (en) * 1995-07-07 1997-08-05 Competitive Technologies, Inc. Herpes simplex virus glycoprotein D variants
US6291207B1 (en) * 1995-07-28 2001-09-18 Northwestern University Herpes virus entry receptor protein
EP0904278A4 (en) * 1996-03-22 1999-09-15 Human Genome Sciences Inc MOLECULE II INDUCER OF APOPTOSIS
US6479254B2 (en) * 1996-03-22 2002-11-12 Human Genome Sciences, Inc. Apoptosis inducing molecule II
WO1998003648A1 (en) * 1996-07-19 1998-01-29 Takeda Chemical Industries, Ltd. Fas ligand-like protein, its production and use
JP4090092B2 (ja) * 1996-07-19 2008-05-28 武田薬品工業株式会社 新規Fasリガンド様タンパク質およびそのDNA
BR9712670A (pt) * 1996-10-25 1999-10-19 Biogen Inc Receptores para linfotoxina-beta, anticorpos anti-receptor para linfotoxina, e anticorpos antiligante de linfotoxina como agentes terapêuticos para o tratamento de doencas imunológicas
WO1998018824A1 (en) * 1996-10-30 1998-05-07 Human Genome Sciences, Inc. Human tumor necrosis factor receptor-like 2
JP2001524985A (ja) * 1997-05-12 2001-12-04 スミスクライン・ビーチャム・コーポレイション ヒト腫瘍壊死因子受容体様2(tr2)抗体
US6346388B1 (en) * 1997-08-13 2002-02-12 Smithkline Beecham Corporation Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2
US6051385A (en) * 1997-10-22 2000-04-18 The Regents Of The University Of Michigan Compositions and methods for identifying and testing therapeutics against HSV infection
AU2972199A (en) * 1998-02-20 1999-09-06 Reinhard Ebner Apoptosis inducing molecule ii and methods of use

Similar Documents

Publication Publication Date Title
CA2296737A1 (en) Ligand for herpes simplex virus entry mediator and methods of use
Sternsdorf et al. Two Nuclear Dot‐Associated Proteins, PML and SplOO, are Often Co‐Autoimmunogenic in Patients with Primary Biliary Cirrhosis
Johnson et al. Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI
Nicola et al. Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM
Diefenbach et al. Herpes simplex virus tegument protein US11 interacts with conventional kinesin heavy chain
Okazaki et al. BHV-1 adsorption is mediated by the interaction of glycoprotein gIII with heparinlike moiety on the cell surface
Wang et al. Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells
Robertson et al. The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ (kappa)
AU779461C (en) Osteoprotegerin binding proteins and receptors
CA2475604C (en) An herpes simplex virus complex
AU690601B2 (en) Vector, viral protein, nucleotide sequence coding therefor and method for inhib iting immune recognition
JP2003502283A5 (cg-RX-API-DMAC7.html)
CA2289912A1 (en) Human receptor proteins; related reagents and methods
CA2332570A1 (en) Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine
Couvineau et al. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29
MULLER et al. Covalent cross‐linking of vasoactive intestinal peptide (VIP) to its receptor in intact colonic adenocarcinoma cells in culture (HT 29)
FI113298B (fi) Diagnostinen reagenssi, menetelmä ja testitarvikesarja EBV:n vasta-aineiden detektoimiseksi
Lee et al. Suppression of tetradecanoyl phorbol acetate-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus by K1 signal transduction
US6998108B1 (en) Antibodies to p30 polypeptides and methods making and using same
JP2024508088A5 (cg-RX-API-DMAC7.html)
CA2406132A1 (en) Ligand for herpes simplex virus entry mediator and methods of use
Li et al. Glycoprotein Bb, the N-terminal subunit of bovine herpesvirus 1 gB, can bind to heparan sulfate on the surfaces of Madin-Darby bovine kidney cells
WO1999020761A3 (en) Compositions and methods for identifying and testing therapeutics against hsv infection
Peng et al. A 7-kDa protein encoded by the BamhI-H gene family of Mareks-disease virus is produced in lytically and latently infected-cells
CA2404679A1 (en) Adenine binding g-protein coupled receptors